4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-024322
Chief Operating Officer sold 100,000 shares
- Chief Operating Officer acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kling Douglas F · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +90,782 | 134,782 | D |
| 2025-02-18 | Sale : show line 2 in the form 10b5-1 | −90,782 | 44,000 | D |
| 2025-02-19 | Exercise or conversion : show line 3 in the form 10b5-1 | +9,218 | 53,218 | D |
| 2025-02-19 | Sale : show line 4 in the form 10b5-1 | −9,218 | 44,000 | D |
| Open-market sales · 100,000 sh | ||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 5 in the form 10b5-1 Option (right to buy) | −90,782 | 135,363 | D |
| 2025-02-19 | Exercise or conversion : show line 6 in the form 10b5-1 Option (right to buy) | −9,218 | 126,145 | D |
Loading xslF345X05/ownership.xml…